Catalyst Wire Dossier Catalyst Wire Dossier

Ultibro Breezhaler

indacaterol; glycopyrronium bromide · Novartis Europharm Limited
Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for Ultibro Breezhaler, covering 2017-10-11 to 2025-07-25. Get the full timeline:

Most recent: EMA Authorised: Ultibro Breezhaler (indacaterol;glycopyrronium bromide) — Novartis Europharm Limited

See pricing